Company chart and information is provided by TradingView based on 15-minute-delayed data.
Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3 the central protein in the complement cascade.
| Website: | www.apellis.com |
| Email: | investors@apellis.com |
| Main Phone: | +1 617 977-5700 |
| Address: | 100 Fifth Avenue |
| Address 2: | Suite A |
| State: | MA |
| City / Town: | Waltham |
| Country: | US |
| Postal Code: | 02451 |
| Exchange: | NGS |
| CEO: | Cedric Francois |
| Employees: | 374 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
